Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990–2010) during first or second complete remission (CR) to identify factors associated with lo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Bejanyan, Nelli, Weisdorf, Daniel J., Logan, Brent R., Wang, Hai-Lin, Devine, Steven M., de Lima, Marcos, Bunjes, Donald W., Zhang, Mei-Jie
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329076/
https://ncbi.nlm.nih.gov/pubmed/25460355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.11.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki